Tenderwize
Retour à la recherche

Delivery of general hospital medicinal products for UMBAL Dr. Georgi Stranski EAD - Pleven

УНИВЕРСИТЕТСКА МНОГОПРОФИЛНА БОЛНИЦА ЗА АКТИВНО ЛЕЧЕНИЕ - Д-Р ГЕОРГИ СТРАНСКИ ЕАД·гр. Плевен, Bulgaria·BGN 44.2M·Deadline Feb 07, 2028 · 528 days left·Restricted·Supplies·DPS
Inscrivez-vous pour sauvegarderOpen documents
Structured notice only
Titre original de l'avis

Bulgaria – Pharmaceutical products – Доставка на общоболнични лекарствени продукти за нуждите на „УМБАЛ Д-р Георги Странски” ЕАД – гр. Плевен

70/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesDPSOpen
Pourquoi ce score ?

Opportunité

70 / 100

Complexité

65 / 100

Facteurs de risque

Notice type is 'cn-standard' (contract award) subtype 16, but the procedure is flagged as a DPS with restricted procedu...

Structured data indicates EU-funded (isEuFunded: true), but XML notice shows 'FundingProgramCode: no-eu-funds'. This af...

Restricted procedure — pre-qualification required

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • BGN 44.2M estimated value
  • Dynamic Purchasing System (DPS)
  • Supplies contract
  • 1 lot
  • Duration 36 MONTH
  • Supply of 655 hospital pharmaceutical products (general medicines) to UMBAL Dr. Georgi Stranski EAD in Pleven, Bulgaria
  • Deliveries made upon written requests over a 36-month period
Afficher le résumé complet

This tender by University Multi-Profile Hospital for Active Treatment 'Dr. Georgi Stranski' EAD - Pleven (Bulgaria) seeks a supplier for the delivery of 655 general hospital pharmaceutical products via a Dynamic Purchasing System (DPS) under a restricted procedure. The estimated total value is BGN 44,239,186.49 (approx. €22.6M) for a 36-month period. Award is based solely on lowest price. The notice is a contract award (cn-standard) with subtype 16, but the DPS nature and long deadline (2028) raise procedural ambiguities. The structured data indicates EU funding, but the XML notice states no EU funds. Only notice-level data was analyzed; procurement documents were not reviewed.

Risques

Notice type is 'cn-standard' (contract award) subtype 16, but the procedure is flagged as a DPS with restricted procedu...

Structured data indicates EU-funded (isEuFunded: true), but XML notice shows 'FundingProgramCode: no-eu-funds'. This af...

Restricted procedure — pre-qualification required

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Tenderer must be registered as a trader with the right to wholesale medicinal products
  • Must hold a wholesale distribution authorization from the Bulgarian Drug Agency (IAL) or equivalent EU authority
  • If producer, must hold a manufacturing authorization; otherwise, an authorization from the manufacturer

Les exigences peuvent être incomplètes.

Critères d'attribution

Lot 1

Award based solely on lowest total price for the lot; no other criteria.

Acheteur

Localisation

гр. Плевен, BGR

Profil acheteur

Ouvrir le profil

Identifiant

114532352

Activité

Health

Lots (1)

LOT-0001

Delivery of general hospital medicinal products for UMBAL Dr. Georgi Stranski EAD - Pleven

Single lot covering the supply of 655 different hospital pharmaceutical products, delivered as needed per written requests over 36 months. The lot is part of a DPS with restricted procedure. Performance location: Pleven, Bulgaria (BG314).

SuppliesDPSEU fundedElectronic submission

BGN 44.2M

Valeur estimée

Localisation

Плевен, Bulgaria

Durée

36 MONTH

Catégorie

Pharmaceutical products

Critères d'attribution

Price

Date limite

Deadline Feb 07, 2028

Détails de la procédure

Date de publication
17 Feb 2025
Langues
Bulgarian

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
107390-2025

Documents (1)

Document de consultation 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30